Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06487936Recruiting

Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion

Role: lead

NCT05916092Enrolling By Invitation

Post-Market Clinical Study on a Modular SI Joint Fusion System

Role: lead

NCT04218838Not ApplicableTerminated

Comparison of CornerLoc SI Joint Stabilization and Steroid Injections for Sacroiliac Joint Dysfunction

Role: lead

All 3 trials loaded